Tafenoquine Oral Tablet

Drug identity checked against registry records

Also recorded as ARAKODA™; KODATEF™

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Tafenoquine in Patients With Mild to Moderate COVID-19NCT0453334760 Degrees Pharmaceuticals LLCPhase 2Completed2022-06-30Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.